Sangam Rajak

Lucknow, UP, India

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications

Inhibition of histone-lysine N-methyltransferase G9a exacerbates alcoholic steatohepatitis (ASH) in mice.

Inhibition of histone-lysine N-methyltransferase G9a exacerbates alcoholic steatohepatitis (ASH) in mice.

Journal: Biochemical and biophysical research communications
Published: November 24, 2025

Microplastics in metabolic dysfunction-associated steatotic liver disease: An emerging threat to liver health.

Microplastics in metabolic dysfunction-associated steatotic liver disease: An emerging threat to liver health.

Journal: World journal of hepatology
Published: June 25, 2025

Histone lactylation: A key epigenetic modulator in the pathogenesis of metabolic dysfunction-associated steatohepatitis and alcoholic steatohepatitis.

Histone lactylation: A key epigenetic modulator in the pathogenesis of metabolic dysfunction-associated steatohepatitis and alcoholic steatohepatitis.

Journal: World journal of hepatology
Published: June 24, 2025

Extracellular RNA mediates iron-induced toxicity and inflammatory signalling in hepatic cells.

Extracellular RNA mediates iron-induced toxicity and inflammatory signalling in hepatic cells.

Journal: Toxicology reports
Published: March 31, 2025

Inhibition of histone methyltransferase G9a aggravates phenotypic severity of hepatic lipotoxicity in non-alcoholic steatohepatitis (NASH).

Inhibition of histone methyltransferase G9a aggravates phenotypic severity of hepatic lipotoxicity in non-alcoholic steatohepatitis (NASH).

Journal: Biochemical and biophysical research communications
Published: December 06, 2024

Dehydroepiandrosterone (DHEA)-induced autophagy protects against lipotoxicity in hepatic cells.

Dehydroepiandrosterone (DHEA)-induced autophagy protects against lipotoxicity in hepatic cells.

Journal: Molecular and cellular endocrinology
Published: November 27, 2024

Liver-specific thyroid hormone receptor-β agonism alleviates alcoholic steatohepatitis (ASH) in mice.

Liver-specific thyroid hormone receptor-β agonism alleviates alcoholic steatohepatitis (ASH) in mice.

Journal: Biochemical and biophysical research communications
Published: September 19, 2024

Autophagy and hepatic lipid metabolism: mechanistic insight and therapeutic potential for MASLD.

Autophagy and hepatic lipid metabolism: mechanistic insight and therapeutic potential for MASLD.

Journal: npj metabolic health and disease
Published: March 30, 2024

Dynamics of cellular plasticity in non-alcoholic steatohepatitis (NASH).

Dynamics of cellular plasticity in non-alcoholic steatohepatitis (NASH).

Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: January 15, 2024

Cell-type specific role of autophagy in the liver and its implications in non-alcoholic fatty liver disease.

Cell-type specific role of autophagy in the liver and its implications in non-alcoholic fatty liver disease.

Journal: World journal of hepatology
Published: January 09, 2024

Myocardial ischemia-reperfusion injury released cellular fibronectin containing domain A (CFN-EDA): A destructive positive loop amplifying arterial thrombosis formation and exacerbating myocardial reperfusion injury.

Myocardial ischemia-reperfusion injury released cellular fibronectin containing domain A (CFN-EDA): A destructive positive loop amplifying arterial thrombosis formation and exacerbating myocardial reperfusion injury.

Journal: Thrombosis research
Published: January 03, 2024

Targeting Extracellular RNA Mitigates Hepatic Lipotoxicity and Liver Injury in NASH.

Targeting Extracellular RNA Mitigates Hepatic Lipotoxicity and Liver Injury in NASH.

Journal: Cells
Published: July 24, 2023
Showing 1-12 of 34

Last Updated: 09/26/2026